dep cabazitaxel
star pharma
['dep cabazitaxel', 'cabazitaxel', 'improve ', 'prostate']
starpharma today reported additional positive data for dep cabazitaxel in heavily pre-treated, late-stage #prostatecancer patients. this data was presented at , and illustrates the potential for dep cabazitaxel to improve patient outcomes. 
Starpharma Holdings Limited (ASX:SPL, OTCQX:SPHRY). ASX 300 company and world leader in the development of dendrimer products.